Enovis inks eCential takeover to develop surgical ortho robots
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
Enovis inks eCential takeover to develop surgical ortho robots Read More »
Medtronic invests $700M in Cornerstone Robotics
Medtronic will gain rights to distribute the Hong Kong-based company’s Sentire surgical robot in certain markets outside the U.S. alongside its own Hugo system.
UniQure files for FDA, UK approval of first gene therapy for Huntington’s disease
The biologics license application follows months of public speculation—and regulatory reversals—for uniQure’s AMT-130. If accepted by the FDA for priority review, approval could come in the second quarter of 2027.
UniQure files for FDA, UK approval of first gene therapy for Huntington’s disease Read More »
Follow the money: How funding announcements can help identify jobs before they’re posted
Funding announcements can signal future hiring activity, giving biotech professionals a chance to build relationships before positions are posted. Industry experts share how to identify the funding events, milestones and company indicators most likely to lead to new jobs.
Follow the money: How funding announcements can help identify jobs before they’re posted Read More »
Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battle
Novartis is planning to file for remibrutinib’s expanded approval in relapsing multiple sclerosis by next year, putting it just behind Roche’s own BTK inhibitor fenebrutinib.
Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battle Read More »
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
CSL Vifor holds the marketing authorization for Tavneos in the U.K., where the drug is marketed as Avacopan Vifor. It continues to be sold on the U.S. market by Amgen despite concerns raised by the FDA.
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing Read More »
Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical models
Efficacy plateaus, muscle loss and weight rebound are testing the limits of GLP-1 success, pushing companies toward new mechanisms and multitarget designs to close the gap. But progress depends on understanding disease biology and selecting the right drug candidates to derisk clinical trials.
Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical models Read More »
Método revolucionario para transmitir información en rayos de luz sin que las turbulencias atmosféricas la distorsionen
Unos científicos han ideado una nueva forma de enviar información en rayos láser a través de la atmósfera sin que dicha información sea alterada por las turbulencias atmosféricas, un problema, este último, que tradicionalmente ha impedido el us …
El satélite astronómico Pandora comienza a investigar atmósferas de planetas de otros sistemas solares
Pandora, un satélite astronómico de la NASA que fue lanzado al espacio el 11 de enero de 2026, completó su fase de comprobaciones y ajustes y ahora ya está haciendo observaciones sin precedentes de planetas de fuera de nuestro sistema solar y de las estrellas alrededor de …
Ventajas de que el padre o la madre hayan vivido cien años
¿Hasta qué punto tener un padre o una madre que ha llegado a los cien años de edad asegura que la persona habrá recibido de ese progenitor una herencia genética más beneficiosa que la que habría recibido si tal progenitor hubiera vivido solo hasta la …
Ventajas de que el padre o la madre hayan vivido cien años Read More »